Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Efficacy and Safety of SDN-037

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Be at least 2 years of age on the date of assent or 18 years of age at the date of consent~2. Be able and willing to follow study instructions and complete all required visits~3. Females of childbearing potential must not be pregnant (as confirmed by a negative urine pregnancy test~4. Able to self-instill the IP or have a caregiver available to instil all doses of the IP~Exclusion Criteria:~1. Any known allergy or hypersensitivity to difluprednate therapy~2. An acute ocular infection (bacterial, viral or fungal) or active ocular inflammation in the study eye~3. Any active corneal pathology noted in the study eye~4. Currently suffering from alcohol and/or drug abuse

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- SDN-037 (Type: EXPERIMENTAL): None
- vehicle (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).